Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06563531

Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,274 (estimated)
Sponsor
Clinique Pasteur Lanroze · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Venous thrombosis and pulmonary embolism are considered serious and potentially preventable complications of hip and knee replacement surgery. The risks of thrombosis must be weighed against the risks associated with preventive measures, both mechanical and pharmacological. Modern medicine is now questioning the use of elastic restraints in surgery. Several studies have investigated the benefits of using restraints to prevent thromboembolic events. These studies have shown no additional benefit from the use of compression stockings in thromboembolism prevention. To the best of our knowledge, no orthopedic study has investigated the non-inferiority of pharmacological treatment compared with elastic compression devices, specifically in knee and hip surgery. The aim of this multicenter, prospective, randomized study is to investigate whether pharmacological prophylaxis alone is non-inferior to pharmacological and mechanical prophylaxis (using restraints) of peripheral venous thrombosis or pulmonary embolism up to 90 days after prosthetic surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREPharmacological thromboprophylaxis and elastic compressionPatients benefit from thromboembolism prevention through pharmacological thromboprophylaxis and elastic restraint after total hip or knee arthroplasty.
PROCEDUREPharmacological thromboprophylaxis without elastic compressionPatients benefit from thromboembolism prevention through pharmacological thromboprophylaxis only after total hip or knee arthroplasty.

Timeline

Start date
2024-11-15
Primary completion
2027-06-15
Completion
2027-07-15
First posted
2024-08-21
Last updated
2026-04-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06563531. Inclusion in this directory is not an endorsement.